Latest News

Mon, April 23, 2012
Kentucky Heart Foundation receives grant to further Healthy Kids, Healthy Communities Intiative
ASHLAND, Ky. –The Kentucky Heart Foundation recently received a $40,000 Action Communities for Health, Innovation, and Environmental change, or ACHIEVE, grant from the National Association of Chronic Disease Directors. The grant supports the efforts of the Healthy Kids, Healthy Communities Coalition, which is made up of more than 75 individuals representing 27 organizations from Boyd and Greenup counties. In addition, the local effort will work with Covington, Ky., to begin development of the ACHIEVE initiative in their community.The grant was one of only 15 awarded nationally. The goal of ACHIEVE is to help communities prevent chronic disease and improve the health of the community through policy, systems and environmental change strategies.

Mon, April 23, 2012
Kentucky Heart Foundation’s CME Program Receives Six-Year Accreditation with Commendation
ASHLAND, Ky. – The Kentucky Heart Foundation’s continuing medical education program has earned six-year accreditation with commendation from the Kentucky Medical Association. As an accredited CME body, the Kentucky Heart Foundation reviews programs and course content for the continuing education of physicians. These programs are designed to maintain, develop or increase the knowledge, skills and professional performance of physicians in providing services to patients, the public, or the profession.

Mon, November 14, 2011
Kentucky Heart Foundation receives $10,000 grant
The Kentucky Heart Foundation, in partnership with the Healthy Kids, Healthy Communities Coalition and ACHIEVE initiative, recently received a $10,000 grant from the Foundation for a Healthy Kentucky to advocate for complete streets in Boyd and Greenup counties.

We Support a Healthier Future - Healthy People 2020

Recently Added Trials

SCORE Registry

The primary purpose of this registry is to track problems with and long-term performance of St. Jude Medical continuous rhythm devices.

ACUITY (closed - results published)

This trial’s results were published in the New England Journal of Medicine in November 2006. It explored the potential of the injectable anti-clotting medicine Angiomax® (bivalirudin) in patients experiencing ACS. The results showed that Angiomax, in the “Angiomax alone” treatment group, was effective and reduced the risk of major bleeding—a key risk factor for mortality—by 47 percent compared to the standard combination of injectable drugs.

PROVIDE (closed)

The objective of the post-marketing surveillance study id to collect clinical usage patterns of the Benephit Infusion Systems. As a result, AngioDynamics will be able to (1) Better understand and quantify usage patterns including patient characteristics, adjunctive procedures, and infusion agents, (2) Collect user-interface information and overall customer satisfaction, and (3) Monitor post-marketing device performance and safety for quality adherence.

APPRAISE 2 (closed - results published)

The purpose of this study is to determine if apixaban is superior to placebo for preventing cardiovascular death, non-fatal myocardial infarction, or ischemic stroke in subjects with a recent acute coronary syndrome.